Real performance. Clear context.
We publish verified ad spend and attributed revenue — shown exactly as recorded, with return on advertising spend calculated from the two. Every figure below comes from a real Genexa Scaling campaign. We never invent case studies, client logos, or testimonials.
What the clinic was facing before the engagement — the capacity, the market, and the gap in their acquisition.
The Genexa patient acquisition activity applied: advertising, capture, follow-up, qualification, and scheduling.
Verified ad spend and attributed revenue, with ROAS calculated from the two. Shown exactly as recorded.
How revenue was tracked, and what the figures exclude — staff time, overhead, and lifetime value.
Real attribution data. Zero fabricated metrics.
Each case study reports the situation, the acquisition work, and verified ad spend and attributed revenue — with ROAS calculated from the two, exactly as recorded.
Interventional Pain Consultants
A direct-to-patient acquisition channel for an established interventional pain practice.
An established interventional pain practice had built its book on physician referrals and payer relationships, but had no owned, measurable way to reach patients directly. They wanted a patient acquisition channel they could turn on, scale, and read like a P&L — instead of waiting on referrals alone.
- Meta advertising (Facebook & Instagram)
- Local patient-demand targeting
- Inquiry capture and lead forms
- Follow-up and response management
- Inquiry qualification
- Consultation scheduling coordination
- Confirmation and attendance reporting
Attributed revenue is reported directly from the practice's campaign attribution — the same records the clinic uses to track revenue tied to acquired patients. Ad spend is the verified media spend recorded against the campaign. ROAS is calculated as attributed revenue ÷ ad spend.
Figures reflect attributed revenue, not total patient lifetime value or net profit, and exclude clinic staff time, follow-up costs, and overhead. This engagement ran across the clinic's full tracking period. Past performance is not a guarantee of future results.
Vitale Health — Frisco
A 37-day scale sprint to fill stem cell consultation capacity in a competitive regenerative market.
A stem cell clinic in a competitive regenerative medicine market needed to fill consultation capacity quickly — and prove that paid acquisition could produce attended, revenue-generating consultations rather than clicks and inquiries that never converted. The goal was a focused sprint with clean, attributable numbers, not an open-ended lead count.
- Meta advertising (Facebook & Instagram)
- Practitioner-led creative
- Inquiry capture and lead forms
- Rapid follow-up and qualification
- Consultation scheduling coordination
- Appointment confirmation & reminders
- Spend, revenue & ROAS reporting
Attributed revenue is reported directly from the clinic's campaign attribution over the 37-day sprint. Ad spend is the verified media spend recorded against the campaign. ROAS is calculated as attributed revenue ÷ ad spend.
Figures reflect attributed revenue over a 37-day sprint, not total patient lifetime value or net profit, and exclude clinic staff time, follow-up costs, and overhead. A short sprint is not representative of a sustained, always-on program. Past performance is not a guarantee of future results.
Want to become a verified case study?
Apply to work with Genexa and, with your permission, your results can be featured here.
Read: the metrics that actually matter